Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies

(2013) P. Neelakantan et al.   BLOOD

EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience

(2012) E. Jabbour et al.   BLOOD

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

(2012) H. Kantarjian et al.   BLOOD

Acute myeloid leukemia in the real world: why population-based registries are needed

(2012) G. Juliusson et al.   BLOOD

Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: A systematic review of efficacy and safety data

(2012) Massimo Breccia et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

(2011) J. Hasford et al.   BLOOD

Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry

(2011) Edgar Faber et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Survival of Patients with Chronic Myelocytic Leukemia: Comparisons of Estimates from Clinical Trial Settings and Population-Based Cancer Registries

(2011) D. Pulte et al.   ONCOLOGIST

Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome

(2010) Mieke J. Aarts et al.   EUROPEAN JOURNAL OF CANCER

The incidence of and mortality from leukaemias in the UK: a general population-based study

(2009) Fatima Bhayat et al.   BMC CANCER

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

(2009) A Hochhaus et al.   LEUKEMIA

The completeness of the Swedish Cancer Register – a sample survey for year 1998

(2008) Lotti Barlow et al.   ACTA ONCOLOGICA

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

(2008) G. Juliusson et al.   BLOOD

A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials

(2008) C M Lucas et al.   LEUKEMIA

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

(2008) M Rohrbacher et al.   LEUKEMIA